Peptide Dimerization as a Strategy for the Development of Antileishmanial Compounds
Molecules · 2024
DOI: 10.3390/molecules29215170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Natália C S Coelho und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara 14800-903, SP, Brazil. Hauptthemen laut MEDLINE: Antiprotozoal Agents, Peptides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, FAPESP, National Council of Scientific and Technological Development.
Abstract (Originalsprache)
Leishmaniasis is recognized as a serious public health problem in Brazil and around the world. The limited availability of drugs for treatment, added to the diversity of side effects and the emergence of resistant strains, shows the importance of research focused on the development of new molecules, thus contributing to treatments. Therefore, this work aimed to identify leishmanicidal compounds using a peptide dimerization strategy, as well as to understand their mechanisms of action. Herein, it was demonstrated that the dimerization of the peptide TSHa, (TSHa)2K, presented higher potency and selectivity than its monomeric form when evaluated against Leishmania mexicana and Leishmania amazonensis. Furthermore, these compounds are capable of inhibiting the parasite cysteine protease, an important target explored for the development of antileishmanial compounds, as well as to selectively interact with the parasite membranes, as demonstrated by flow cytometry, permeabilization, and fluorescence microscopy experiments. Based on this, the identified molecules are candidates for use in in vivo studies with animal models to combat leishmaniasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara 14800-903, SP, Brazil.
- Department of Biochemistry and Organic Chemistry, Institute of Chemistry, São Paulo State University (UNESP), Araraquara 14800-060, SP, Brazil.
ORCID-Profile: Natália C S Coelho, Deivys L F Portuondo, Jhonatan Lima, Iracilda Z Carlos, Eduardo M Cilli, Márcia A S Graminha
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- FAPESP
- National Council of Scientific and Technological Development
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES)
Zitieren
APA
Coelho, N. C. S., Portuondo, D. L. F., Lima, J., Velásquez, A. M. A., Valente, V., Carlos, I. Z., Cilli, E. M., & Graminha, M. A. S. (2024). Peptide Dimerization as a Strategy for the Development of Antileishmanial Compounds. Molecules. https://doi.org/10.3390/molecules29215170
Vancouver
Coelho NCS, Portuondo DLF, Lima J, Velásquez AMA, Valente V, Carlos IZ, et al. Peptide Dimerization as a Strategy for the Development of Antileishmanial Compounds. Molecules. 2024. doi:10.3390/molecules29215170
BibTeX
@article{Coelho2024,
author = {Coelho, Natália C S and Portuondo, Deivys L F and Lima, Jhonatan and Velásquez, Angela M A and Valente, Valéria and Carlos, Iracilda Z and Cilli, Eduardo M and Graminha, Márcia A S},
title = {Peptide Dimerization as a Strategy for the Development of Antileishmanial Compounds},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29215170}
}
EUVIMED